Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Brogidirsen by Nippon Shinyaku for Duchenne Muscular Dystrophy: Likelihood of Approval
Brogidirsen is under clinical development by Nippon Shinyaku and currently in Phase II for Duchenne Muscular Dystrophy. According to GlobalData,...